Guangzhou Jet Bio-Filtration Co Ltd
SSE:688026

Watchlist Manager
Guangzhou Jet Bio-Filtration Co Ltd Logo
Guangzhou Jet Bio-Filtration Co Ltd
SSE:688026
Watchlist
Price: 15.51 CNY -2.58% Market Closed
Market Cap: ¥2.2B

EV/EBIT

20.8
Current
15%
Cheaper
vs 3-y average of 24.5

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
20.8
=
Enterprise Value
¥3B
/
EBIT
¥122.2m

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
20.8
=
Enterprise Value
¥3B
/
EBIT
¥122.2m

Valuation Scenarios

Guangzhou Jet Bio-Filtration Co Ltd is trading below its 3-year average

If EV/EBIT returns to its 3-Year Average (24.5), the stock would be worth ¥18.28 (18% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+42%
Average Upside
34%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 20.8 ¥15.51
0%
3-Year Average 24.5 ¥18.28
+18%
5-Year Average 28.1 ¥21.02
+36%
Industry Average 29.4 ¥21.98
+42%
Country Average 28.9 ¥21.6
+39%

Forward EV/EBIT
Today’s price vs future ebit

Not enough data available to calculate forward EV/EBIT

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Guangzhou Jet Bio-Filtration Co Ltd
SSE:688026
Average EV/EBIT: 27
20.8
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available
18%
N/A
JP
Hoya Corp
TSE:7741
33.6
N/A N/A
CH
Alcon AG
SIX:ALC
28
26%
1.1
DK
Coloplast A/S
CSE:COLO B
14.9
7%
2.1
US
Align Technology Inc
NASDAQ:ALGN
19.7
21%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
17.9
21%
0.9
CA
Bausch + Lomb Corp
NYSE:BLCO
54.5
72%
0.8
JP
A
Asahi Intecc Co Ltd
TSE:7747
32.4
N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
20.9
10%
2.1
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -76.7 N/A N/A
P/E Multiple
Earnings Growth PEG
CN
Guangzhou Jet Bio-Filtration Co Ltd
SSE:688026
Average P/E: 33.2
27
26%
1
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
JP
Hoya Corp
TSE:7741
38.6
15%
2.6
CH
Alcon AG
SIX:ALC
37.3
32%
1.2
DK
Coloplast A/S
CSE:COLO B
23.5
21%
1.1
US
Align Technology Inc
NASDAQ:ALGN
33
34%
1
UK
ConvaTec Group PLC
LSE:CTEC
32.7
41%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.5 N/A N/A
JP
A
Asahi Intecc Co Ltd
TSE:7747
50.3
40%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.3
9%
2.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -36.2 N/A N/A

Market Distribution

In line with most companies in China
Percentile
38th
Based on 5 337 companies
38th percentile
20.8
Low
0 — 16.6
Typical Range
16.6 — 52.9
High
52.9 —
Distribution Statistics
China
Min 0
30th Percentile 16.6
Median 28.9
70th Percentile 52.9
Max 49 021

Guangzhou Jet Bio-Filtration Co Ltd
Glance View

Market Cap
2.2B CNY
Industry
Health Care

Guangzhou Jet Biofiltration Co., Ltd. engages in the research and development, manufacture, and sale of biological laboratory consumables. The company is headquartered in Guangzhou, Guangdong and currently employs 1,431 full-time employees. The company went IPO on 2020-01-22. The firm focuses on disposable plastic consumables for cell culture and related liquid handling biological laboratories. Its main products include biological culture type and liquid handling type, as well as reagents and small laboratory equipment. The firm distributes its products in domestic and to overseas markets.

Intrinsic Value
14.11 CNY
Overvaluation 9%
Intrinsic Value
Price ¥15.51
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett